Dr. Guohui Sun received his PhD degree from Beijing University of Technology, Beijing, China at July, 2017. Later, he worked as a Postdoctor in the same group for two years. After the Postdoctoral experience, he formally joined Beijing University of Technology as an associate Professor/doctoral Supervisor at August, 2019. His research area focuses on the field of Molecular Toxicology and Applied Pharmacology, including three main aspects: (1) Tumor Pharmacology; (2) Drug Theoretics and Computational toxicology; and (3) Cheminformatics in drug discovery and environmental toxicology. He has a good contribution towards the scientific and academic community with numerous research publications in highly prestigious international journals and various presentations in both national and international conferences. He is the senior member of Chinese Pharmaceutical Association, the member of American Chemistry Society, Chinese Chemical Society, Chinese Pharmacological Society and Chinese Society of Biomedical Engineering. He got the 2019/2020 MDPI outstanding reviewer’s representative awards. He is the Editorial board member of Frontiers in Bioscience-Landmark (SCI, IF:3.1); Young Editorial Board Member: Chemical Reagents (Chinese Core Journal); Guest Editor-in-Chief: Molecules (SCI, IF:4.6), Cells (SCI, IF:6.0) and Frontiers in Molecular Biosciences (SCI, IF:5.0).